참고문헌 (66)

1. Muttenthaler M , King GF , Adams DJ , Alewood PF . Trends in peptide drug discovery . Nat Rev Drug Discov . 2021 ; 20 : 309 – 25 . 

2. Fosgerau K , Hoffmann T . Peptide therapeutics: current status and future directions . Drug Discov Today . 2015 ; 20 : 122 – 8 . 

3. Lau JL , Dunn MK . Therapeutic peptides: Historical perspectives, current development trends, and future directions . Bioorg Med . 2018 ; 26 : 2700 – 7 . 

4. Uhlig T , Kyprianou T , Martinelli FG , Oppici CA , Heiligers D , Hills D , Calvo XR , Verhaert P . The emergence of peptides in the pharmaceutical business: From exploration to exploitation . EuPA Open Proteom . 2014 ; 4 : 58 – 69 . 

   상세보기

5. Kaspar AA , Reichert JM . Future directions for peptide therapeutics development . Drug Discov Today . 2013 ; 18 : 807 – 17 . 

6. https://www.fda.gov/media/107622/download. Accessed October 12, 2021 

7. Kristensen K , Henriksen JR , Andresen TL . Adsorption of cationic peptides to solid surfaces of glass and plastic . PLoS One . 2015 ; 10 : e0122419 . 

   상세보기

8. Goebel‐Stengel M , Stengel A , Taché Y , Reeve Jr , JR . The importance of using the optimal plasticware and glassware in studies involving peptides . Anal Biochem . 2011 ; 414 : 38 – 46 . 

   상세보기

9. Kraut A , Marcellin M , Adrait A , Kuhn L , Louwagie M , Kieffer‐Jaquinod S , Lebert D , Masselon CD , Dupuis A , Bruley C . Peptide storage: are you getting the best return on your investment? Defining optimal storage conditions for proteomics samples . J Proteome Res . 2009 ; 8 : 3778 – 85 . 

   상세보기

10. Audain E , Ramos Y , Hermjakob H , Flower DR , Perez‐Riverol Y . Accurate estimation of isoelectric point of protein and peptide based on amino acid sequences . Bioinformatics 2016 ; 32 : 821 – 7 . 

    상세보기

11. Sikora K , Jaśkiewicz M , Neubauer D , Migoń D , Kamysz W . The role of counter‐ions in peptides—an overview . Pharmaceuticals 2020 ; 13 : 442 . 

    상세보기

12. Mant CT , Chen Y , Yan Z , Popa TV , Kovacs JM , Mills JB , Tripet BP , Hodges RS . Peptide characterization and application protocols . Totowa, NJ : Humana Press ; 2007 . 

13. Smith JB . Peptide sequencing by Edman degradation . e LS . 2001 . 

14. Hunkapiller M , Hewick R , Drewer W , Hood L . Peptide sequencing by Edman degradation . Meth Enzymol . 1983 ; 91 : 15 . 

15. Strack R . Solving the primary structure of peptides . Nat Methods . 2015 ; 12 : https://doi.org/10.1038/nmeth.3524. 

    상세보기

16. Pauling L , Corey RB , Branson HR . The structure of proteins: two hydrogen‐bonded helical configurations of the polypeptide chain . Proc Natl Acad Sci USA . 1951 ; 37 : 205 – 11 . 

    상세보기

17. Bolotina I , VIu L . Determination of the secondary structure of proteins from circular dichroism spectra. IV. Contribution of aromatic amino acid residues into circular dichroism spectra of proteins in the peptide region . Mol Biol . 1985 ; 19 : 1409 – 21 . 

18. Greenfield NJ . Using circular dichroism spectra to estimate protein secondary structure . Nat Protoc . 2006 ; 1 : 2876 – 90 . 

    상세보기

19. Kelly SM , Price NC . The use of circular dichroism in the investigation of protein structure and function . Curr Protein Pept Sci . 2000 ; 1 : 349 – 84 . 

    상세보기

20. Den Engelsman J , Garidel P , Smulders R , Koll H , Smith B , Bassarab S , Seidl A , Hainzl O , Jiskoot W . Strategies for the assessment of protein aggregates in pharmaceutical biotech product development . Pharm Res . 2011 ; 28 : 920 – 33 . 

    상세보기

21. Pignataro MF , Herrera MG , Dodero VI . Evaluation of peptide/protein self‐assembly and aggregation by spectroscopic methods . Molecules 2020 ; 25 : 4854 . 

    상세보기

22. Manning MC , Chou DK , Murphy BM , Payne RW , Katayama DS . Stability of protein pharmaceuticals: an update . Pharm Res . 2010 ; 27 : 544 – 75 . 

    상세보기

23. Bhatt NP , Patel K , Borchardt RT . Chemical pathways of peptide degradation. I. Deamidation of adrenocorticotropic hormone . Pharm Res . 1990 ; 7 : 593 – 9 . 

    상세보기

24. Wang W . Instability, stabilization, and formulation of liquid protein pharmaceuticals . Int J Pharm . 1999 ; 185 : 129 – 88 . 

    상세보기

25. Joshi AB , Kirsch LE . The relative rates of glutamine and asparagine deamidation in glucagon fragment 22–29 under acidic conditions . J Pharm Sci . 2002 ; 91 : 2332 – 45 . 

26. Zapadka KL , Becher FJ , Gomes dos Santos A , Jackson SE . Factors affecting the physical stability (aggregation) of peptide therapeutics . Interf Focus . 2017 ; 7 : 20170030 . 

27. Geiger T , Clarke S . Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide‐linked reactions that contribute to protein degradation . J Biol Chem . 1987 ; 262 : 785 – 94 . 

    상세보기

28. Torosantucci R , Schöneich C , Jiskoot W . Oxidation of therapeutic proteins and peptides: structural and biological consequences . Pharm Res . 2014 ; 31 : 541 – 53 . 

    상세보기

29. Ji JA , Zhang B , Cheng W , Wang YJ . Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization . J Pharm Sci . 2009 ; 98 : 4485 – 500 . 

    상세보기

30. D'Hondt M , Bracke N , Taevernier L , Gevaert B , Verbeke F , Wynendaele E , De Spiegeleer B . Related impurities in peptide medicines . J Pharm Biomed Anal . 2014 ; 101 : 2 – 30 . 

    상세보기

31. Cromwell ME , Hilario E , Jacobson F . Protein aggregation and bioprocessing . AAPS J . 2006 ; 8 : E572 – 9 . 

    상세보기

32. Liu S , Zhou L , Chen L , Dastidar SG , Verma C , Li J , Tan D , Beuerman R . Effect of structural parameters of peptides on dimer formation and highly oxidized side products in the oxidation of thiols of linear analogues of human β‐defensin 3 by DMSO . J Pept Sci . 2009 ; 15 : 95 – 106 . 

    상세보기

33. Ohtake S , Kita Y , Arakawa T . Interactions of formulation excipients with proteins in solution and in the dried state . Adv Drug Deliv Rev . 2011 ; 63 : 1053 – 73 . 

    상세보기

34. Narang AS , Desai D , Badawy S . Impact of excipient interactions on solid dosage form stability . Pharm Res . 2012 ; 29 : 2660 – 83 . 

    상세보기

35. Byrn SR , Xu W , Newman AW . Chemical reactivity in solid‐state pharmaceuticals: formulation implications . Adv Drug Deliv Rev . 2001 ; 48 : 115 – 36 . 

    상세보기

36. Kamerzell TJ , Esfandiary R , Joshi SB , Middaugh CR , Volkin DB . Protein–excipient interactions: Mechanisms and biophysical characterization applied to protein formulation development . Adv Drug Deliv Rev . 2011 ; 63 : 1118 – 59 . 

    상세보기

37. Wu LC , Chen F , Lee SL , Raw A , Lawrence XY . Building parity between brand and generic peptide products: regulatory and scientific considerations for quality of synthetic peptides . Int J Pharm . 2017 ; 518 : 320 – 34 . 

    상세보기

38. Carr D . A guide to the analysis and purification of proteins and peptides by reversed‐phase HPLC . Adv Chromatogr Technol . 2016: 2 – 63 . 

39. https://www2.chem.wisc.edu/deptfiles/genchem/netorial/modules/biomolecules/modules/protein1/prot13.htm. Accessed October 12, 2021. 

40. https://proteinstructures.com/structure/amino‐acids. Accessed October 14, 2021. 

41. Hou Y , Yin Y , Wu G . Dietary essentiality of “nutritionally non‐essential amino acids” for animals and humans . Exp Biol Med . 2015 ; 240 : 997 – 1007 . 

42. Moldoveanu SC , David V . Selection of the HPLC method in chemical analysis . Amsterdam, NL : Elsevier ; 2017 . 

43. https://www.waters.com/waters/en_US/PracticalApproachestoPeptideIsolationMethodDevelopmentConsiderations/nav.htm?cid=134929200&locale=en_US. Accessed October 21, 2021. 

44. McCalley DV . Choice of buffer for the analysis of basic peptides in reversed‐phase HPLC . LC GC NAM . 2005 ; 23 : 162 – 81 . 

    상세보기

45. McCalley DV . Effect of buffer on peak shape of peptides in reversed‐phase high performance liquid chromatography . J Chromatogr A . 2004 ; 1038 : 77 – 84 . 

    상세보기

46. Shibue M , Mant C , Hodges R . Effect of anionic ion‐pairing reagent concentration (1–60 mM) on reversed‐phase liquid chromatography elution behaviour of peptides . J Chromatogr A . 2005 ; 1080 : 58 – 67 . 

    상세보기

47. Verbeke F , Bracke N , Debunne N , Wynendaele E , De Spiegeleer B . LC–MS compatible antiadsorption diluent for peptide analysis . Anal Chem . 2019 ; 92 : 1712 – 9 . 

48. Prasad S , Mandal I , Singh S , Paul A , Mandal B , Venkatramani R , Swaminathan R . Near UV‐visible electronic absorption originating from charged amino acids in a monomeric protein . Chem Sci . 2017 ; 8 : 5416 – 33 . 

    상세보기

49. Mant CT , Cepeniene D , Hodges RS . Reversed‐phase HPLC of peptides: Assessing column and solvent selectivity on standard, polar‐embedded and polar endcapped columns . J Sep Sci . 2010 ; 33 : 3005 – 21 . 

    상세보기

50. https://www.waters.com/webassets/cms/library/docs/720002975en.pdf Accessed November 2, 2021. 

51. Stoll DR , Carr PW . Two‐dimensional liquid chromatography: a state of the art tutorial . Anal Chem . 2017 ; 89 : 519 – 31 . 

    상세보기

52. Wang X , Buckenmaier S , Stoll D . The growing role of two‐dimensional LC in the biopharmaceutical industry . J Appl Bioanal . 2017 ; 3 : 120 . 

53. https://www.agilent.com/cs/library/primers/public/5991‐2359EN.pdf. Accessed November 2, 2021. 

54. Tognarelli D , Tsukamoto A , Caldwell J , Caldwell W . Rapid peptide separation by supercritical fluid chromatography . Bioanalysis 2010 ; 2 : 5 – 7 . 

    상세보기

55. Molineau J , Hamel Y , Hideux M , Hennig P , Bertin S , Mauge F , Lesellier E , West C . Analysis of short‐chain bioactive peptides by unified chromatography‐electrospray ionization mass spectrometry. Part I. Method development . J Chromatogr A . 2021 ; 1658 : 462631 . 

    상세보기

56. Molineau J , Hideux M , Hennig P , Bertin S , Mauge F , Lesellier E , West C . Analysis of short‐chain bioactive peptides by unified chromatography‐electrospray ionization mass spectrometry. Part II. Comparison to reversed‐phase ultra‐high performance liquid chromatography . J Chromatogr A . 2022 ; 1663 : 462771 . 

57. Fekete S , Beck A , Veuthey J‐L , Guillarme D . Theory and practice of size exclusion chromatography for the analysis of protein aggregates . J Pharm Biomed Anal . 2014 ; 101 : 161 – 73 . 

    상세보기

58. Oliva A , Llabrés Ma , Fariña JB . Comparative study of protein molecular weights by size‐exclusion chromatography and laser‐light scattering . J Pharm Biomed Anal . 2001 ; 25 : 833 – 41 . 

    상세보기

59. Hong P , Koza S , Bouvier ES . A review size‐exclusion chromatography for the analysis of protein biotherapeutics and their aggregates . J Liq Chromatogr Relat Technol. 2012 ; 35 : 2923 – 50 . 

    상세보기

60. Wen J , Arakawa T , Philo JS . Size‐exclusion chromatography with on‐line light‐scattering, absorbance, and refractive index detectors for studying proteins and their interactions . Anal Biochem . 1996 ; 240 : 155 – 66 . 

    상세보기

61. https://www.bio‐rad.com/en‐in/applications‐technologies/ion‐exchange‐chromatography Accessed November 4, 2021. 

62. Ó’Fágáin C , Cummins PM , O'Connor BF . Protein chromatography . New York, NY : Springer Science + Business Media ; 2017 . 

63. Yamamoto S , Nakanishi K , Matsuno R . Ion‐exchange chromatography of proteins . Boca Raton, FL : CRC Press , 1988 . 

64. Jungbauer A , Hahn R . Ion‐exchange chromatography . Meth Enzymol . 2009 ; 463 : 349 – 71 . 

65. Fekete S , Beck A , Veuthey J‐L , Guillarme D . Ion‐exchange chromatography for the characterization of biopharmaceuticals . J Pharm Biomed Anal . 2015 ; 113 : 43 – 55 . 

    상세보기

66. Torrado A , Valiente M . The effect of resin particle size on the rate of ion release: interactions in mixed bed systems . Anal Bioanal Chem . 2004 ; 378 : 205 – 13 . 

    상세보기